NasdaqGM - Nasdaq Real Time Price USD
Travere Therapeutics, Inc. (TVTX)
21.00
-0.09
(-0.40%)
As of 10:01:02 AM EDT. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-160,664
-237,475
-280,021
-186,291
-14,792
Investing Cash Flow
35,717
99,325
55,776
-32,553
-137,623
Financing Cash Flow
143,665
139,422
218,752
117,573
231,683
End Cash Position
61,969
58,535
58,176
61,688
165,753
Income Tax Paid Supplemental Data
--
--
--
--
16,420
Interest Paid Supplemental Data
--
8,838
8,838
10,159
7,327
Capital Expenditure
-106,530
-101,212
-41,591
-28,366
-24,151
Issuance of Capital Stock
--
134,738
191,198
19,545
224,934
Issuance of Debt
--
0
0
316,250
0
Repayment of Debt
--
0
0
-211,324
0
Free Cash Flow
-267,194
-338,687
-321,612
-214,657
-38,943
12/31/2021 - 11/8/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VERA Vera Therapeutics, Inc.
21.23
+0.19%
MIRM Mirum Pharmaceuticals, Inc.
44.68
+0.65%
VRNA Verona Pharma plc
67.98
+1.10%
CRNX Crinetics Pharmaceuticals, Inc.
31.22
-0.22%
ASND Ascendis Pharma A/S
155.20
-1.27%
KRYS Krystal Biotech, Inc.
130.48
-0.69%
TARS Tarsus Pharmaceuticals, Inc.
42.89
-0.02%
RARE Ultragenyx Pharmaceutical Inc.
34.76
+0.10%
JANX Janux Therapeutics, Inc.
23.54
+4.05%
SWTX SpringWorks Therapeutics, Inc.
46.24
+0.04%